[1] The Human Evidence Gap and Where Research Is Heading The most intellectually honest statement about BPC-157 is this: an unusually robust preclinical literature has established a plausible and broadly consistent mechanistic picture, while the human clinical trial evidence remains essentially absent
The Remarkable Benefits: How This Peptide Supports Healing This peptide acts as a master regulator of the healing process
In contrast to PDGF-BB, in diabetic wounds, induced by alloxan application, BPC 157 largely promoted mature collagen in granulation tissue (Seveljevic-Jaran et al., 2006) (note, previously, BPC 157 healed alloxan-induced gastric lesions in rats (Petek et al., 1999))
Being able to return to previously limited activities often matters more than achieving a completely pain-free state
The studies, reported in Circulation: Arrhythmia and Electrophysiology , point to natriuretic peptide oligomers as pro-arrhythmia mediators in the atria and support a causative role for mutant ANP in the pathophysiology of the associated inherited AFib